Latest Coagulopathy Stories
MarketReportsOnline.com adds Global Hemophilia Market Report: 2015 Edition research report of 51 pages on the hemophilia industry to the pharmaceuticals intelligence collection of its research store.
Runners in the upcoming Allscripts Tobacco Road Marathon can hit the trail to help raise funds to Stop the Clot® and support the educational efforts of the National Blood Clot Alliance.
PLAINSBORO, N.J., April 17, 2015 /PRNewswire/ -- Novo Nordisk is proud to celebrate World Hemophilia Day, which aims to raise awareness of the disease and other inherited bleeding disorders.
PLAINSBORO, N.J., March 26, 2015 /PRNewswire/ -- Novo Nordisk today announced the company will launch Novoeight(®) (Antihemophilic Factor [Recombinant]) in the United States for people living
-- Using Mutant Protein, CHOP Hematologist Safely Removes Unwanted Antibodies, Reverses Hemophilia in Dog Model of Bleeding Disease -- PHILADELPHIA, March 13, 2015 /PRNewswire-USNewswire/
FLINT, Mich., Nov. 4, 2014 /PRNewswire/ -- American Homecare Federation, a Diplomat company (NYSE: DPLO), is celebrating 25 years of business this year.
An Educational Program Based on the Findings From the Hemophilia Experiences, Results, and Opportunities (HERO) Study Launched at NHF's 66th Annual Meeting NEW YORK and PLAINSBORO,
National Hemophilia Foundation Encourages Patient Community to Take an Active Part in Strategies, Policies, and Programs Directly Affecting Their Lives at 66th Annual Meeting in Washington, DC
Randy Fenninger to Lead Organization With Strategic Focus Aimed at Increasing Recognition of Life-Threatening Blood Clots and Their Impact on Public Health Rockville,
First Recombinant Treatment Approved in US for Patients With GT With Refractoriness to Platelet Transfusions, With or Without Antibodies to Platelets PLAINSBORO, N.J., July 7, 2014 /PRNewswire/
- A woman chauffeur.
- A woman who operates an automobile.